Presented by:
Dr. William Hollifield, MD
Assistant Professor
University of Florida, College of Pharmacy
Faculty Disclosure:
Dr. Hollifield has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationships to disclose.
Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.
Release Date: September 29, 2022
Expiration Date: September 28, 2025
Target Audience: All physicians
Learning Objectives:
As a result of participation in this activity, participants should be able to:
- Review the opioid crisis.
- Review the methamphetamine crisis.
- Describe the impact of the opioid/stimulant crisis on the healthcare system.
- Examine the role of the Addiction Medicine Consult Service.
Requirements for successful completion: Certificates are awarded upon successful completion (80% proficiency) of the post-test.
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Resource(s) for further study:
- Mattson CLTrends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths – United States, 2013-2019. MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2020, CDC WONDER Online Database, released 12/2021.
- National Vital Statistics System, Mortality File. https://wonder.cdc.gov/
- Mason M, JM. Notes from the Field: Opioid Overdose Deaths Before, During, and After an 11-Week COVID-19 Stay-at-Home Order – Cook County, Illinois, January 1, 2018-October 6, 2020. MMWR Morb Mortal Wkly Rep 2021;70.
- Wainwright JJ, Mikre M, Whitley P, et al. Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak. JAMA. 2020;324(16):1674-1677.
- Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021 Sep 22.
- Englander, et al, Converging Crises: Caring for Hospitalized Adults with Substance Use Disorder in the Time of COVID-19. J. Josp. Med 2020;10:628-630.
- Weinstein Zoe M., Wakeman Sarah E., Nolan Seonaid. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med. Clin. North Am. 2018 Jul; 102(4):587-601.
- Qeadan F, Tingey B, Bern R, et al. Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data. EClinicalMedicine. 2021;37:100938. Doi:10.1016/j.eclinm.2021.100938.
- Priest Kelsey C., McCarty Dennis. Role of the Hospital in the 21st Century Opioid Overdose Epidemic: The Addiction Medicine Consult Service. J Addict Med March/April 2019; 13(2):104-112. doi:10.1097/ADM.0000000000000496
- Priest Kelsey C., McCarty Dennis. Making the business case for an addiction medicine consult service: a qualitative analysis. BMC Health Services Research. 2019
- Harris, M.T.H., Peterkin, A., Bach, P. et al. Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract 16, 13 (2021).
If you have any questions please feel free to contact Nancy Boyd at (352) 594-4298 or at nancy.boyd@ufl.edu